FundaMental Pharma raises €2.7M Seed round
11 April 2024· Heidelberg, Germany· health, neuroscience, biotech, b2b, deep_hardware
The additional funding will support the development of the orally administered clinical candidate FMP374 from IND-enabling studies through early clinical phases.
Investors
LeadNovartis Venture Fund
Also participating
High-Tech GründerfondsBioGeneration VenturesCoparionThuja Capital
About FundaMental Pharma
Stage
Seed
Headquarters
Heidelberg, Germany
Founded
2016
Team Size
6–20
Sectors
healthneurosciencebiotechb2bdeep_hardware